Publications by authors named "A M Gharaibeh"
Objectives: The aim of this study was the evaluation of a group of patients treated at the Department of Orthopaedics and Traumatology of Locomotory Apparatus at Luis Pasteur University Hospital in Košice for septic arthritis in relation to risk factors and chronic diseases and its microbial aetiologic profile.
Methods: We conducted a retrospective study of patients including all episodes of septic arthritis from March 2013 to August 2022. The occurrence of chronic diseases, risk factors and its microbiological profile were investigated.
Objective: Our research was focused to find a relation between the occurrence of spondylodiscitis and occurrence of chronic diseases. We were trying to discover some new risk factors and relations between chronic disorders in our research group. This analysis was also focused to detect factors that prolong the hospitalization of patients and worsen their prognosis.
View Article and Find Full Text PDFArticle Synopsis
- Biologics and oral small molecules (OSM) are effective treatments for inflammatory bowel disease (IBD), but concern exists over their potential to increase risks of major adverse cardiovascular events (MACE) and venous thromboembolism (VTE).
- Using a multi-institutional database, the study matched IBD patients on biologics and OSM with similar patients not on these treatments to assess MACE and VTE risks from 30 days to 3 years post-prescription.
- Results indicated that biologic-treated IBD patients had lower risks of MACE and VTE after 1 and 3 years, while OSM users showed reduced all-cause mortality but no significant difference in MACE or VTE risks, suggesting
Background: The impact of COVID-19 on pregnancy remains a critical area of research, with growing evidence suggesting that maternal infection, particularly in the third trimester, may lead to significant complications Aims: The primary aim was to investigate the maternal and neonatal outcome of pregnant Jordanian women with COVID-19. The secondary aim included exploring demographics, obstetrics characteristics, and comorbidities among these women.
Methods: A retrospective comprehensive review of the records of 300 cases of pregnant women with COVID-19, who were treated between November 2020 and April 2021 at Queen Alia Military Hospital (a main referral center for patients with COVID-19) in Jordan.
Aims: Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI-related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI-related adverse events. Additionally, whether incident irM portends worse long-term CV outcomes remains unclear.
View Article and Find Full Text PDF